PATENT CLAIM ANALYSIS

Application Number: 15748786
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["544", "350000"]

Abstract:
Compounds of the formula Ia or of the formula Ib in which X, Y, R 1  and R 2  have the meanings indicated in claim  1 , are inhibitors of pyruvate dehydrogenase kinase (PDHK), and can be employed, inter alia, for the treatment of diseases such as cancer.

Claim (Index 8):
Compounds of the formula Ia or Ib according to  claim 1  and pharmaceutically acceptable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios, for the use for the treatment and/or prevention of cancer, diabetes, heart ischemia, insulin resistance syndrome, metabolic syndrome, hyperglycemia, dyslipidemia, atherosclerosis, cardiac failure, cardiomyopathy, myocardial ischemia, hyperlactacidemia, mitochondrial disease, mitochondrial encephalomyopathy.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 86.0
- Lexical Diversity: 1.4
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15105154', '09927324', '12298369', '14342749', '14420003']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7947461816851022
- 35 USC 102 Novelty (BERT): 0.5419649787297918
- Combined Prediction Score: 0.7694680613895712
- Mean Citation Score: 375.832478
- Max Citation Score: 391.2317
- Similarity Product: 238.8803374008775

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test